Photomedicine Technology Market

Photomedicine Technology Market Size and Share:

The global photomedicine technology market size was valued at USD 498.14 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 761.43 Million by 2033, exhibiting a CAGR of 4.59% during 2025-2033. North America currently dominates the market, holding a significant market share of over 46.0% in 2024. The market is growing steadily, owing to an increase in the frequency of skin problems and chronic consequences, rising demand for aesthetic and cosmetic surgery to improve facial characteristics, and developments in laser technology.

Rising demand for non-invasive treatments, an increase in the frequency of skin illnesses, and expanding applications in cancer, dermatology, and ophthalmology are driving the growth of the photomedicine technology market. Advances in laser and LED-based treatments improve treatment efficacy, which drives acceptance. Rising elderly populations and chronic illness loads, such as cancer and cardiovascular disease, contribute to growth. Expanding aesthetic procedures, such as laser hair removal and skin rejuvenation, increases demand. Government financing and clinical research advances in photodynamic treatment help to drive market growth. Increasing understanding of light-based treatments for pain relief and wound healing is also beneficial. The transition to home-use devices and AI integration in diagnostics hasten adoption. Regulatory approvals and reimbursement regulations have an impact on market dynamics and the pace of technological commercialization.

The growing need for advanced light-based medical therapies is driving growth in the photomedicine industry. Companies that specialize in laser treatment and photobiomodulation are expanding operations to increase manufacturing capacity and address rising healthcare demands. Investments in infrastructure and technological development reflect the growing popularity of non-invasive treatment options in medical and wellness settings. For instance, in June 2024, Aspen Laser Systems, LLC, and TheraLight, LLC, two privately held U.S.-based medical device firms focused on photomedicine, expanded their corporate headquarters and warehouse in Lindon, Utah, to support business growth and operational advancements.

Photomedicine Technology Market Trends:

Increasing Prevalence of Skin Disorders and Chronic Complications

The increasing occurrence of skin disorders and chronic conditions is expanding the photomedicine technology market scope. Skin diseases such as psoriasis, acne, and skin cancer afflict Millions of people around the world. As per the World Psoriasis Day consortium, an estimated 125 Million people worldwide (2%-3% of the global population) live with psoriasis, and approximately 30% of them also develop psoriatic arthritis. Photomedicine techniques, such as phototherapy, are emerging as effective therapies for many illnesses. UV phototherapy is a frequent treatment for psoriasis and other dermatological diseases. It is non-invasive, well-tolerated, and has been demonstrated to alleviate symptoms while improving patient quality of life. In addition, photomedicine is gaining popularity in the treatment of chronic pain. Low-level light treatment (LLLT), also known as photobiomodulation, has been demonstrated to help relieve pain caused by illnesses such as osteoarthritis and musculoskeletal problems. The non-pharmacological nature of LLLT and its ability to target pain at its source make it an attractive opportunity for both patients and healthcare providers. The rising prevalence of chronic ailments, as well as the growing demand for non-invasive, effective therapies, are major drivers of the photomedicine technology industry, establishing it as an essential component of modern healthcare.

Growing Awareness and Acceptance

The growing knowledge and acceptance of light-based therapies among healthcare professionals and patients is a demand for photomedicine technology. This advancement strengthens the efficacy and security of photomedicine procedures. Antoniou et al. conducted a 12-week randomized clinical trial (RCT), that evaluated the KLOX BioPhotonic System, an LED blue light device combined with specific photo-converter chromophores, for moderate-to-severe acne vulgaris. At week 12, 51.7% experienced a ≥2-grade IGA improvement, and 81.6% of treated hemifaces had ≥40% fewer inflammatory lesions. The benefits of photomedicine are becoming more widely acknowledged among healthcare experts, prompting its incorporation into regular medical procedures. Dermatologists are more frequently recommending laser and light-based therapies for various skin conditions due to their precision and minimal side effects. The utilization of photomedicine in dermatology extends beyond cosmetic procedures to include the treatment of conditions like vascular lesions, pigmented lesions, and skin rejuvenation. Patients are also playing a significant role in driving the adoption of photomedicine technologies. They are becoming more educated about available treatment options and are actively seeking non-invasive and effective solutions. The minimal downtime associated with many photomedicine procedures is particularly appealing to patients, as it allows them to resume their daily activities quickly. Furthermore, when people become more aware of the environmental impact of particular therapies, they favor photomedicine approaches. Phototherapy reduces the need for topical drugs, which might have negative environmental consequences if disposed of incorrectly.

Recent Advancements in Medical Research and Technology

The rapid progress in medical research and technology is contributing to the photomedicine technology market revenue. There has been a remarkable evolution in the field of photomedicine, marked by groundbreaking innovations and cutting-edge developments. One of the most significant advancements is in laser technology. Lasers are becoming increasingly precise and versatile, leading to an extensive range of applications in the medical field. The refinement of fractional laser technology has revolutionized cosmetic and dermatological procedures. Fractional lasers create micro-injuries in the skin, stimulating collagen production and improving skin texture. This approach is gaining immense popularity for treating scars, wrinkles, and uneven pigmentation. Additionally, the use of lasers in minimally invasive surgeries (MIS) is expanding, offering patients less pain and faster recovery times. Photodynamic therapy (PDT) is another area where medical research is making remarkable strides. PDT combines photosensitizing agents with specific wavelengths of light to target and destroy cancerous or diseased cells. This non-invasive treatment approach is being applied in the management of various cancers, such as skin cancer and certain types of lung cancer, offering patients a more targeted and less toxic alternative to traditional therapies. The paper Topical Photodynamic Therapy (PDT) in a Medical Centre evaluated 705 patients (2108 lesions) who received PDT. The rates of clearance after 12 months were 53.4% (Actinic Keratosis), 71.3% (Bowenoid AK), 86.4% (Bowen's Disease), 89.0% (superficial Basal Cell Carcinoma), and 89.7% (nodular BCC).

Photomedicine Technology Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global photomedicine technology market, along with forecasts at the global, regional, and country levels from 2025-2033. The market has been categorized based on technology, application, and region.

Analysis by Technology:

• Laser
• Polychromatic Polarized Light
• Full Spectrum Light
• Dichroic Lamps
• Light Emitting Diodes
• Photodynamic Therapy
• Interventional Radiology

Based on the recent photomedicine technology market outlook, photodynamic therapy (PDT) stands out as the largest segment within the photomedicine technology market. PDT is used extensively in the treatment of cancer, especially skin cancers like basal cell carcinoma and actinic keratosis. It involves the administration of photosensitizing agents followed by exposure to light, which activates the agents to target and destroy cancerous cells. The effectiveness and growing acceptance of PDT in oncology have propelled it to the forefront of photomedicine technologies.

Laser technology encompasses numerous applications, including cosmetic procedures like skin resurfacing and tattoo removal and medical treatments for conditions, such as retinal disorders and cancer. The precision and versatility of lasers have made them the preferred options among healthcare providers and patients seeking targeted and MI solutions.

According to the photomedicine technology market insight, polychromatic finds applications in pain management, wound healing, and musculoskeletal conditions. Its non-invasive nature and effectiveness in promoting tissue repair make it a valuable addition to the photomedicine toolkit.

Full spectrum light therapy is employed primarily in the treatment of mood disorders, such as seasonal affective disorder (SAD) and circadian rhythm disturbances. This segment addresses the mental health aspect of photomedicine by providing patients with exposure to natural light, which can have a positive effect on their overall well-being and mood regulation.

Dichroic lamps are used in dermatology and aesthetics for procedures like hair removal and skin rejuvenation. These lamps emit specific wavelengths of light to target melanin or blood vessels, making them effective in various cosmetic treatments. While they have a niche application, they offer precision and efficiency in specific dermatological procedures.

Analysis by Application:

• Aesthetics and Dermatology 
  • Hair Removal
  • Tattoo Removal
  • Skin Resurfacing
  • Others
• Dental Procedures
• Oncology
• Ophthalmology
• Pain Management
• Wound Healing
• Others

Aesthetics and dermatology lead the market with around 35.6% of the market share in 2024. In oncology, photodynamic therapy (PDT), in particular, is gaining prominence in the treatment of various cancers, including skin cancers like basal cell carcinoma and actinic keratosis. PDT involves the administration of photosensitizing agents followed by targeted light exposure to destroy cancer cells. The increasing acceptance and efficacy of PDT in cancer treatment have made it a dominant force within the market, offering patients less invasive and more targeted therapeutic options.

Aesthetics and dermatology include applications like hair removal, tattoo removal, skin resurfacing, and treatment for various skin conditions. Photomedicine technologies, such as laser therapy and light-based procedures, are widely used in this field to provide patients with non-invasive and effective solutions for cosmetic enhancement and skin health.

Photomedicine technologies have found applications in dentistry, particularly in oral surgery and dental aesthetics. Laser technology is commonly used for procedures like gum tissue reshaping, teeth whitening, and the treatment of oral lesions. The precision and minimal invasiveness of photomedicine make it a valuable tool in improving dental patient outcomes and experiences.

Ophthalmology is another essential application segment in photomedicine. Technologies like laser therapy and photocoagulation play a vital role in treating retinal disorders, such as diabetic retinopathy and macular degeneration. These treatments help preserve or improve vision, making them indispensable in the field of eye care.

Photomedicine technologies are increasingly applied in wound healing applications. Low-level light therapy (LLLT) and light emitting diode (LED) therapy are used to promote tissue repair and reduce healing time in chronic wounds, diabetic ulcers, and post-surgical incisions. These non-invasive approaches offer healthcare providers effective tools to improve patient outcomes in wound care.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

In 2024, North America accounted for the largest market share of over 46.0%. The photomedicine technology market in North America is driven by continuous research and development (R&D) efforts which result in cutting-edge devices and therapies. The rising trend in aesthetic and cosmetic procedures is driving the demand for photomedicine technologies in North America.

Asia Pacific maintains a strong presence driven by the rise in medical tourism, with patients seeking cost-effective and high-quality photomedicine treatments.

Europe stands as another key region in the market, driven by the increasing shift towards minimally invasive procedures in both medical and cosmetic fields. Photomedicine technologies, such as lasers and light-emitting diode (LED) therapy, align with this trend by offering less invasive treatment options.

Latin America exhibits growing potential in the photomedicine technology market, fueled by the increasing interest in aesthetic and cosmetic surgery.

The Middle East and Africa region show a developing market for photomedicine technology, driven by the increasing investment in healthcare infrastructure and medical tourism.

Key Regional Takeaways:

United States Photomedicine Technology Market Analysis

The United States photomedicine technology market is heavily influenced by the extensive research and development (R&D), robust regulatory support, and growing use of light-based therapies for dermatology, pain relief, and oncology. Major industry players are driving market growth, while FDA approvals for new laser and LED-based treatments have increased confidence among healthcare providers. In addition, the swift convergence of artificial intelligence (AI) and wearable photomedicine devices is revolutionizing treatment delivery, enhancing the accessibility and efficacy of light-based treatments. The rising demand for non-invasive aesthetic treatments and anti-aging treatments is fueling demand for low-level laser therapy (LLLT) and photobiomodulation therapy (PBMT). Based on the American Society of Plastic Surgeons' 2023 Procedural Statistics Report, 1.6 Million surgical cosmetic procedures and 25.4 Million minimally invasive procedures were conducted in 2023. Minimally invasive procedures increased 7%, 2% ahead of surgical procedures, demonstrating a trend toward less invasive aesthetic improvements. Laser, injectable, and skin rejuvenation devices are leading this trend. In addition, insurance coverage for some photodynamic therapies (PDT) is increasing, enhancing access, although high device prices are a concern. Growing use of home-use phototherapy devices and more partnerships between biotech companies and academic centers are driving market growth in the next few years.

Europe Photomedicine Technology Market Analysis

The market for Europe photomedicine technology is widening as a result of significant government support for medical technology, a rising geriatric population, and increasing numbers of skin disorders, chronic pain, and eye ailments. Germany, France, and the UK are heavily investing in laser therapeutics for oncology, dermatology, and the healing of wounds. The government of the UK initiated the Life Sciences Innovative Manufacturing Fund (LSIMF), which provides EUR 520 Million in capital grants and intends to build UK health resilience through life sciences manufacturing support. Opened between October 30, 2024, and March 31, 2030, it provided financing for human medicines and MedTech projects of a value of EUR 8 Million+, paying 10-20% of the overall project value. The European Medicines Agency (EMA) is boosting the growth of photodynamic treatments (PDT) and laser therapies that don't require entry into the skin, resulting in increased product clearances. Expanding demand for light-based regenerative medicine, especially in stimulating stem cells and tissue engineering, is driving business growth. Dermatology for aesthetic purposes, such as lasers used for peeling the skin and LED-inspired anti-aging procedures, also serves as an important driver. The market is also being helped by wearable phototherapy products and growing telemedicine uses, making it easier to get treatment.

Asia Pacific Photomedicine Technology Market Analysis

The Asia-Pacific region is experiencing rapid growth, driven by medical tourism, rising disposable income, and government healthcare investments. Countries such as China, Japan, South Korea, and India are leading in advanced laser treatments for dermatology, pain relief, and cancer therapy. According to reports, 7.3 Million medical tourists are expected in India in 2024, contributing 10-12% of hospital revenue, with growth projected at twice the industry rate in FY25. Max Healthcare reported 27% YoY growth, while Fortis and Apollo Hospitals are expanding international patient outreach, according to the India Brand Equity Foundation. South Korea’s aesthetic industry drives demand for LED skincare treatments, supported by cosmetic technology and medical tourism. China’s expanding biophotonics sector is advancing PDT for cancer treatment, while Japan invests in phototherapy for neurological and musculoskeletal disorders, enhancing pain management and neurorehabilitation. Meanwhile, local manufacturing of cost-effective phototherapy devices is making treatments more accessible.

Latin America Photomedicine Technology Market Analysis

The photomedicine technology market in Latin America is expanding due to growing awareness of non-invasive treatments, rising medical tourism, and increasing dermatology clinics. Brazil and Mexico lead in cosmetic laser treatments, hair regrowth therapies, and pain management. High UV exposure is driving demand for photodynamic therapy (PDT) and LED-based skin treatments, particularly as Brazil’s National Cancer Institute (INCA) predicts 101,920 men and 118,570 women will develop non-melanoma skin cancer annually (2023-2025). In 2020, the disease caused 1,534 male and 1,119 female deaths. Government healthcare initiatives and private investment in laser technologies are supporting growth, but high device costs and limited reimbursement policies remain barriers. Local manufacturers are addressing affordability concerns with cost-effective LED therapy devices. Expanding chronic pain management and wound healing applications will further drive market growth.

Middle East and Africa Photomedicine Technology Market Analysis

In the Middle East and Africa (MEA), the market is growing due to rising aesthetic treatments, medical tourism in the UAE, and increasing laser therapy adoption for dermatology. Saudi Arabia and the UAE lead in phototherapy investments, focusing on advanced dermatology and pain management. At Arab Health 2025, King Faisal Specialist Hospital & Research Centre (KFSHRC) highlighted AI diagnostics, robotic surgeries, and telemedicine, attracting 46,476 new patients in 2024, with a 47.39% rise in medical tourism from 17 countries. Demand for laser-based tattoo removal, acne treatment, and hair restoration is increasing. Africa’s limited healthcare infrastructure and high equipment costs remain challenges, though government initiatives in South Africa and Egypt are improving access. Expanding telemedicine and mobile health applications are enhancing market accessibility.

Competitive Landscape:

The photomedicine technology industry is booming with new product launches, partnerships, collaborations, and R&D initiatives. These activities are largely motivated by the rising need for non-invasive medical treatments and advances in light-based therapies. Product launches and strategic alliances stand out among these advancements, depicting the industry's dynamic and collaborative approach to meeting changing healthcare demands. The report has also analyzed the competitive landscape of the market with some of the key players being:

• Biolitec AG
• Candela Corporation
• Colorado Skin & Vein
• Lumenis Be Ltd.
• Lumibird
• Photomedex Inc.
• Sisram Medical Ltd
• Thor Photomedicine Ltd.

Latest News and Developments:

• July 2024: TheraLight, LLC launched the TheraLight 360+ full-body photobiomodulation therapy bed. It has a 360º shape with 45,000 LEDs in four wavelengths (633nm, 810nm, 850nm, 940nm) and 25% more power than the previous model. The device increases pain relief, cognitive function, skin health, and wound healing.
• July 2024: Aspen Laser Systems launched the Ascent Laser Series, a 32-watt quad-wave therapeutic laser with 670nm, 810nm, 980nm, and 1064nm wavelengths. FDA-cleared, it reduces pain and inflammation while stimulating collagen and blood circulation. Units are now available for shipment.
• March 2024: CLINUVEL presented its SCENESSE (afamelanotide) drug and photomedicine advancements to German investors. The company started conducting a Phase III trial for vitiligo and expanding into PhotoCosmetics, including CYACÊLLE solar screen. CLINUVEL aims to broaden melanocortin applications and strengthen its market presence.
• February 2023: Biolitec AG announced the launch of the new unique and high-power diode laser LEONARDO DUAL 200, which can effectively lower the risk of ejaculation issues in the treatment of benign prostatic hyperplasia (BPH), among other applications.
• June 2023: Candela Corporation announced that the Vbeam Family of Pulsed Dye Lasers (PDL) had expanded its FDA-cleared indications for the use of the 595 nm wavelength to include the pediatric population (birth to 21 years of age) for the treatment of cutaneous capillary malformations, also known as port wine stains (PWS), and infantile hemangiomas (IH)/congenital hemangiomas.
• August 2023: Lumibird announced the acquisition of Convergent Photonics, which would increase its autonomy in semiconductor and very high-power fiber laser technologies.

Photomedicine Technology Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the photomedicine technology market from 2019-2033.
• The photomedicine technology market research report provides the latest information on the market drivers, challenges, and opportunities in the global market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's Five Forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the photomedicine technology industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.